Sandor Victor

Sandor Victor is listed in filings as Director at Merus N.V.. This profile follows SEC Form 4 activity through Dec 12, 2025, including sale activity. Recent filings connect the profile to Merus N.V. (MRUS), Prelude Therapeutics Incorporated (PRLD), Kymera Therapeutics, Inc. (KYMR), and ADC Therapeutics S.A. (ADCT). The current snapshot covers public activity from Jun 14, 2024 to Dec 12, 2025. Reported amounts are shown as $548.8K to $335.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.